Lack of FDA resources extends clinical hold on ALS drug NUZ-001
Due to a lack of resources and personnel, the FDA has delayed until October its decision on lifting a clinical hold on ALS drug NUZ-001.| ALS News Today
Due to a lack of resources and personnel, the FDA has delayed until October its decision on lifting a clinical hold on ALS drug NUZ-001.| ALS News Today
Patricia Inacio is a science writer for ALS News Today with a PhD in cell biology. She covers the latest news and information on a variety of amyotrophic lateral sclerosis topics.| ALS News Today
The analyses offer evidence for a slowing of functional decline and improved survival outcomes with long-term Radicava ORS by ALS patients.| ALS News Today
